VALNEVA SE WKN: A0MVJZ ISIN: FR0004056851 Kürzel: VLA Forum: Aktien Thema: Hauptdiskussion

The ADSs intended to be sold under the Sales Agreement, if any, will be issued and sold pursuant to the shelf registration statement on Form F-3 (File No. 333- 286071) (the 'Registration Statement'), which was also renewed in conjunction with the filing of the Company's Annual Report on Form 20-F on March 24, 2025, once declared effective by the SEC (that will become effective, subject to completion of SEC review). The ADSs are listed on the Nasdaq Global Market under the symbol 'VALN', and the Company's ordinary shares are listed on the regulated market of Euronext in Paris under the symbol 'VLA'. To the extent that ADSs are sold pursuant to the ATM Program, the Company currently intends to use the net proceeds (after deduction of fees and expenses), if any, of sales of ADSs issued under the ATM Program, together with its existing cash and cash equivalents, primarily to fund the manufacturing, commercialization, research and development of the Company's products and product candidates, working capital and other general corporate purposes, at the Company's discretion. For any ADSs requested to be sold by the Company to eligible investors, Jefferies, as sales agent, will use commercially reasonable efforts to arrange the sale on the Company's behalf, consistent with Jefferies' normal sales and trading practices. Sales prices may vary based on market prices and other factors. Only eligible investors (as described in greater detail below) may purchase ADSs under the ATM Program. The ADSs and the underlying ordinary shares may be issued, if any, through one

^Saint-Herblain (France), March 26, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) ('Valneva' or the 'Company'), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its registration statement on Form F-3, filed on March 25, 2025 with the U.S. Securities and Exchange Commission ('SEC') relating to its existing At-the- Market offering facility (the 'ATM Program'), which was originally entered into in August 2022 and has not been utilized to-date. Pursuant to this financing program, the Company has the option to offer and sell, including with unsolicited investors who have expressed an interest, a total gross amount of up to $75.0 million of American Depositary Shares ('ADS'), each ADS representing two of the Company's ordinary shares, from time to time in sales deemed to be an 'at the market offering' as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, and pursuant to the terms of an Amended and Restated Open Market Sale Agreement (the 'Sales Agreement') with Jefferies LLC ('Jefferies'), acting as sales agent, subject to French regulatory limits and within the limits of the investors' requests expressed in the context of the ATM Program. The timing of any potential future sales will depend on a variety of factors and the Company is not under any obligation to utilize the ATM Program in a specified amount or at all. The terms and conditions of the new ATM Program remain similar to the prior ATM program set up in August 2022. The Sales Agreement will terminate when the maximum program amount is reached or it is terminated early in accordance with its terms.

Das ist die News für ADR das mit der Verwässerung was anscheinend keine ist oder doch ist

Es gibt New's. Könnte die jemand in deutsch posten, bitte.

Super Henry, danke

VALNEVA SE - RENOUVELLE SON CONTRAT DE PLACEMENT DANS LE CADRE DE SON PROGRAMME « AT--MARKET (ATM) » EXISTANT * VALNEVA SE - A DÉPOSÉ AUPRÈS DE LA SEC UN SUPPLÉMENT DE PROSPECTUS DANS LE CADRE DU RENOUVELLEMENT DE SA DÉCLARATION D'ENREGISTREMENT SUR FORMULAIRE F-3 * VALNEVA SE - GRÂCE À CE PROGRAMME, PEUT ÉMETTRE JUSQU'À $75 MLNS SOUS FORME D'AMERICAN DEPOSITARY SHARES, CHAQUE ADS REPRÉSENTANT 2 ACTIONS ORDINAIRES * VALNEVA SE - LES TERMES ET CONDITIONS DU NOUVEAU PROGRAMME ATM DEMEURENT SIMILAIRES À CEUX DU PRÉCÉDENT PROGRAMME ATM MIS EN PLACE EN AOÛT 2022 * VALNEVA SE - LE CONTRAT DE PLACEMENT (SALES AGREEMENT) PRENDRA FIN EN CAS D'ATTEINTE DU MONTANT MAXIMUM DU PROGRAMME OU DE RÉSILIATION ANTICIPÉE

war klar, dass Qube wieder erhöht um 0,17%

Auch wenn der ausgerufene Preis sehr hoch sein sollte, dividiert man ihn durch 2 ist er wieder niedrig. Und ohne einer News das SecFiling finde ich sehr fragwürdig. Nichts desto trotz erhoffe ich mir einen positiven Ausgang

bin sowas von entspannt da die aufgerufenen Preise für Shares relativ hoch sind.

War auch nicht auf Valneva bezogen, Gott bewahre 😃…! Damit meinte ich die Börse allgemein…

Was ist jetzt heute wieder los? Da wollten doch safe noch Leute im niedrigen 3€ Bereich rein... deswegen die Abverkäufe gestern!

Das ist nur Täuschung, bald rauscht es extrem nach unten.

Du bleibst entspannt?

Ja das ist wieder was anderes

Mach ich stets auch so. Ab und zu verkaufe ich negativ gelaufene Aktien, wenn ich auch positive verkaufe. Zum Gegenrechnen dann muss ich keine Steuer auf den Gewinn zahlen.

Ja aber bei Valneva ist der RS weiiiiittt weg und da brauchen wir nicht darüber reden!